COVID-19 response: CVS, Walgreens ramp up free coronavirus testing outside of stores Drug delivery: Walgreens and FedEx launching next-day prescription delivery service Walgreens had also ...

Last year, the Food and Drug Administration reported problems with the company's proprietary blood-testing device, known as the Edison. "We are disappointed that Walgreens has chosen to terminate ...

Walgreens is expanding its scope ... pharmacies across 33 states and Washington, D.C. The drug store chain, which began offering scheduled testing days at select stores last December, said that ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Walgreens Boots Alliance plans to leverage its network ...

In a reversal, Walgreens drugstores won't be offering ... the non-prescription product after the Food and Drug Administration informed the test maker that its genetic health report sure looked ...

WASHINGTON—The Food and Drug Administration plans to take a look at a new genetic test that Walgreen Co. plans to start selling at 6,000 of its stores this month. The test is designed to predict ...

The latest plank in that platform is its plan to test a pharmacy ... generate far more in annual drug store sales to treat these related conditions. What makes Walgreens’ pilot program worthy ...

His comments come as both CVS and Walgreens recently announced new programs designed to reduce prescription drug prices for many ... care gap closure and diagnostic testing, to work with the ...

The DNA test was supposed to be available at Walgreens stores on Friday — until the Food and Drug Administration started asking questions. The agency challenged San Diego-based Pathway Genomics ...

Walgreens said Wednesday that it will sell its own generic version of over-the-counter Narcan, the lifesaving opioid overdose reversal drug that first rolled out to drugstore shelves last fall.

U.S. District Judge Richard Andrews rejected Walgreens' argument that the arbitrator's decision in a contract dispute over COVID-19 testing was “egregious and improper.” Andrews sided with ...